Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Godavari Biorefineries Limited ( (IN:GODAVARIB) ) has shared an update.
Godavari Biorefineries Limited has been granted a European patent for a novel anticancer molecule, which is now validated in Spain, the UK, and as a Unitary Patent. This development highlights the company’s advancement in the anti-cancer research segment, potentially enhancing its market positioning and offering new opportunities for stakeholders.
More about Godavari Biorefineries Limited
Godavari Biorefineries Limited operates in the biorefinery industry, focusing on the development and production of bio-based chemicals and products. The company is involved in research and innovation, particularly in the field of anti-cancer compounds.
Average Trading Volume: 17,168
Current Market Cap: 12.74B INR
For detailed information about GODAVARIB stock, go to TipRanks’ Stock Analysis page.

